According to a study published in Nature Communications, researchers at the National Institutes of Health (NIH) created an ...
SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...
Brain tumors could soon be detected by robots, according to a new study. Artificial intelligence (AI) models can be trained ...
Prominent vaccine skeptic RFK, Jr., is a proven menace to public health. But with a bird flu outbreak looming, he is poised ...
"Navigating cases involving narcissistic individuals requires a nuanced understanding of their psychodynamics," write Elisa ...
Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has been lifted to 8th place in the 2024 Access to ...
In need of translation services for your global business in London? Explore our guide to the top 10 providers in 2025.
Abbott (NYSE:ABT) announced new data supporting its Amplatzer Amulet left atrial appendage (LAA) occluder system.
The upcoming clinical trial conferences will host talks on supply chain resilience, AI’s growing role and forging industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback